drugset / Trial / NCT04424225

Visual Surround Suppression and Perceptual Expectation Under Psilocybin

NCT04424225 ↗

RandomizedCrossoverTriple-blindBasic science

Summary

The prospective pilot study will address the critical need for more precise characterizations of the acute visual effects of the drug psilocybin by measuring the impact of acute psilocybin intoxication on a perceptual task known as visual surround suppression, compared to an active placebo control.

Timeline

Start
2021-08-30
Primary completion
2023-09-01
Completion
2023-09-01

Outcome

Outcome not reported

Stopped (Business): “Could not secure additional funding to continue the study. Pilot phase of study completed.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Psilocybin Other / unclassified 25 mg —

Indications